• Bloodstream infection provides a novel model of severe systemic inflammation. • Bloodstream infection causes acute, inflammation-associated deficits in attention. • Elevations in biomarkers of brain injury correlate with severity of illness. • At convalescence cognition normalised, but depressive symptoms persisted. • No evidence of persistent blood–brain barrier dysfunction or microglial activation. Sepsis associated encephalopathy is a poorly understood yet common complication of sepsis. Immune challenge and animal models implicate blood–brain barrier (BBB) dysfunction and microglial activation in the hippocampus as key drivers of pathology. In this exploratory study, we used bloodstream infections (BSI) as a model of severe infection to investigate the relationship between changes in cognition with plasma biomarkers of brain injury, BBB permeability and microglial activation quantified using advanced neuroimaging. In this longitudinal exploratory study we recruited patients hospitalised with BSI as well as age matched controls. Cognition was assessed at the bedside and at convalesce using a CANTAB battery. MRI scanning was performed as soon as practicable after hospital discharge. Hippocampal and thalamic BBB permeability was assessed using dynamic enhanced contrast MRI (DCE-MRI). Microglial morphometry was assessed using diffusion-weighted magnetic resonance spectroscopy (DW-MRS) of the left thalamus. Plasma glial fibrillary acidic protein (GFAP) and neurofilament light protein (NFL) were quantified using Single molecule array (SiMoA) technology. 21 patients with BSI and 16 age matched controls were enrolled (median IQR 64.3 51.1–68.5 years). Patients with BSI had poorer cognitive function, particularly attention (RVP A-prime z-score −1.08 95% CI −1.75, −0.61, p < 0.001). This deficit was correlated by the magnitude of the inflammatory response quantified by peak c-reactive protein (CRP). Furthermore, patients with BSI had higher concentrations of NFL, which was correlated with poorer cognitive function and more severe illness. At the scanning visit (median: 32 days from discharge) cognition had largely normalised and was similar to controls. However, patients with BSI had significantly more depressive symptoms (p < 0.01). There were no differences in BBB permeability or metabolite apparent diffusion coefficients between patients with BSI and controls. Our findings suggest that BSI are associated with acute, inflammation-mediated brain injury. However, cognitive dysfunction, particularly in the domain of attention, is temporary and not associated with changes in BBB permeability or microglial activation at convalescence. Given persistent mood dysfunction and elevated biomarkers of neuronal injury longitudinal study is warranted to determine long-term sequelae BSI and other severe infections.
Underwood et al. (Sun,) studied this question.